Effect of pretransplant diabetes on short-term outcomes after liver transplantation: A National cohort study

Liver International

Volumn 35, Issue 7, 2015, Pages 1902-1909

  Hoehn, Richard S ^a   Singhal, Ashish ^a   Wima, Koffi ^a   Sutton, Jeffrey M ^a   Paterno, Flavio ^a   Steve Woodle, E ^a   Hohmann, Sam ^b   Abbott, Daniel E ^a   Shah, Shimul A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

Diabetes; Liver transplant; Outcomes; SRTR; UHC

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMA; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GRAFT FAILURE; GRAFT RECIPIENT; HEMODIALYSIS; HEPATITIS; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; PNEUMONIA; PRIVATE HEALTH INSURANCE; RETROSPECTIVE STUDY; SEPSIS; SHORT TERM SURVIVAL; STUPOR; SURGICAL INFECTION; SURGICAL MORTALITY; THERAPY EFFECT; THROMBOSIS; URINARY TRACT INFECTION; WOUND INFECTION; ADOLESCENT; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ECONOMICS; END STAGE LIVER DISEASE; EPIDEMIOLOGY; FACTUAL DATABASE; GRAFT SURVIVAL; HEALTH CARE PLANNING; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HEALTH RESOURCES; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84931576100     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12770     Document Type: Article

References (33)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
2. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 2004; 27: 2444-9.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
4. Nair S, Vanatta JM, Arteh J, Eason JD. Effects of obesity, diabetes, and prior abdominal surgery on resource utilization in liver transplantation: a single-center study. Liver Transpl 2009; 15: 1519-24.
5. Shields PL, Tang H, Neuberger JM, et al. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999; 68: 530-5.
6. John PR, Thuluvath PJ. Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 2001; 34: 889-95.
7. Volk ML, Hernandez JC, Lok AS, Marrero JA. Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007; 13: 1515-20.
8. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002; 74: 1007-12.
9. Ling Q, Xu X, Wei Q, et al. Impact of preexisting diabetes mellitus on outcome after liver transplantation in patients with hepatitis B virus-related liver disease. Dig Dis Sci 2011; 56: 889-93.
10. Dare AJ, Plank LD, Phillips AR, et al. Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation. Liver Transpl 2014; 20: 281-90.
11. Blanco JJ, Herrero JI, Quiroga J, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl 2001; 7: 226-33.
12. Trail KC, Stratta RJ, Larsen JL, et al. Results of liver transplantation in diabetic recipients. Surgery 1993; 114: 650-6. discussion 56-8
13. Younossi ZM, Stepanova M, Saab S, et al. The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US. Aliment Pharmacol Ther 2014; 40: 686-94.
14. Salvalaggio PR, Dzebisashvili N, Macleod KE, et al. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl 2011; 17: 233-42.
15. OPTN. 2014Transplants by Donor Type. Available from: http://optn.transplant.hrsa.gov/latestData/rptData.asp (accessed 2014 February 12)
16. Macomber C W, Shaw J J, Santry H, et al. Centre volume and resource consumption in liver transplantation. HPB (Oxford) 2012; 14: 554-9.
17. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
18. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-90.
19. Jalisi S, Bearelly S, Abdillahi A, Truong MT. Outcomes in head and neck oncologic surgery at academic medical centers in the United States. Laryngoscope 2013; 123: 689-98.
20. Quillin RC, Wilson GC, Wima K, et al. Neighborhood Level Effects of Socioeconomic Status on Liver Transplant Selection and Recipient Survival. Clin Gastroenterol Hepatol 2014; 12: 1934-41.
21. Ozhathil DK, Li YF, Smith JK, et al. Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl 2011; 17: 1191-9.
22. Singla A, Simons J, Li Y, et al. Admission volume determines outcome for patients with acute pancreatitis. Gastroenterology 2009; 137: 1995-2001.
23. Ata A, Lee J, Bestle SL, Desemone J, Stain SC. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 2010; 145: 858-64.
24. Lane JT, Dagogo-Jack S. Approach to the patient with new-onset diabetes after transplant (NODAT). J Clin Endocrinol Metab 2011; 96: 3289-97.
25. Shaw JJ, Shah SA. Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean? Expert Rev. Gastroenterol Hepatol 2011; 5: 365-70.
26. Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol 2010; 53: 199-206.
27. Kallwitz ER. Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol 2012; 18: 3627-34.
28. Parekh J, Corley DA, Feng S. Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation. Am J Transplant 2012; 12: 2181-7.
29. Axon RN, Williams MV. Hospital readmission as an accountability measure. JAMA 2011; 305: 504-5.
30. Readmissions Reduction Program. Available from: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html (accessed 2014 May 17).
31. Paterno F, Wilson GC, Wima K, et al. Hospital utilization and consequences of readmissions after liver transplantation. Surgery 2014; 156: 871-8.
32. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 2001; 345: 99-106.
33. Birkmeyer NJ, Gu N, Baser O, Morris AM, Birkmeyer JD. Socioeconomic status and surgical mortality in the elderly. Med Care 2008; 46: 893-9.